1. Home
  2. CSBR vs THCH Comparison

CSBR vs THCH Comparison

Compare CSBR & THCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSBR
  • THCH
  • Stock Information
  • Founded
  • CSBR 1985
  • THCH 2018
  • Country
  • CSBR United States
  • THCH China
  • Employees
  • CSBR N/A
  • THCH N/A
  • Industry
  • CSBR Biotechnology: Biological Products (No Diagnostic Substances)
  • THCH Blank Checks
  • Sector
  • CSBR Health Care
  • THCH Finance
  • Exchange
  • CSBR Nasdaq
  • THCH Nasdaq
  • Market Cap
  • CSBR 90.2M
  • THCH 84.2M
  • IPO Year
  • CSBR 1986
  • THCH N/A
  • Fundamental
  • Price
  • CSBR $6.48
  • THCH $2.48
  • Analyst Decision
  • CSBR Strong Buy
  • THCH
  • Analyst Count
  • CSBR 1
  • THCH 0
  • Target Price
  • CSBR $12.00
  • THCH N/A
  • AVG Volume (30 Days)
  • CSBR 15.1K
  • THCH 11.3K
  • Earning Date
  • CSBR 09-15-2025
  • THCH 11-11-2025
  • Dividend Yield
  • CSBR N/A
  • THCH N/A
  • EPS Growth
  • CSBR N/A
  • THCH N/A
  • EPS
  • CSBR 0.21
  • THCH N/A
  • Revenue
  • CSBR $56,878,000.00
  • THCH $187,316,342.00
  • Revenue This Year
  • CSBR $7.31
  • THCH N/A
  • Revenue Next Year
  • CSBR $12.01
  • THCH N/A
  • P/E Ratio
  • CSBR $30.18
  • THCH N/A
  • Revenue Growth
  • CSBR 10.11
  • THCH N/A
  • 52 Week Low
  • CSBR $3.75
  • THCH $1.95
  • 52 Week High
  • CSBR $11.99
  • THCH $5.15
  • Technical
  • Relative Strength Index (RSI)
  • CSBR 47.59
  • THCH 39.20
  • Support Level
  • CSBR $6.29
  • THCH $2.54
  • Resistance Level
  • CSBR $6.79
  • THCH $2.74
  • Average True Range (ATR)
  • CSBR 0.25
  • THCH 0.10
  • MACD
  • CSBR 0.03
  • THCH -0.01
  • Stochastic Oscillator
  • CSBR 33.83
  • THCH 26.07

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About THCH TH International Limited Ordinary shares

TH International Ltd is the parent company of the franchise of Tim Hortons coffee shops and has the rights to operate Tim Hortons coffee shops in mainland China, Hong Kong, and Macau. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. The Company operated under single reportable segment, Tim Hortons. The company's revenue is derived from its operations in the PRC.

Share on Social Networks: